[Federal Register Volume 69, Number 189 (Thursday, September 30, 2004)]
[Notices]
[Page 58543]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-21943]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on August 19, 2004, Mallinckrodt 
Inc., Mallinckrodt & Second Streets, St. Louis, Missouri 63147, made 
application by letter to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of Remifentanil (9739), a basic 
class of controlled substance in Schedule II.
    The firm plans to manufacture the listed controlled substance for 
dosage form manufacture and for distribution in bulk form.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such as substance may file comments or 
objections to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: Federal Register Representative, 
Office of Chief Counsel (CCD) and must be filed no later than November 
29, 2004.

    Dated: September 16, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-21943 Filed 9-29-04; 8:45 am]
BILLING CODE 4410-09-M